153804-42-3 Usage
Uses
Used in Pharmaceutical Research:
1-(2-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)ethyl)-4-(2-methoxyphenyl)piperazine is used as a research tool for studying the inhibition of glycogen synthase kinase 3 (GSK-3) due to its potential therapeutic applications in treating various diseases.
Used in Cancer Treatment Research:
In the field of oncology, 1-(2-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)ethyl)-4-(2-methoxyphenyl)piperazine is used as a potential therapeutic agent for the treatment of various types of cancer, given its ability to inhibit GSK-3, a protein kinase involved in cellular processes relevant to cancer development and progression.
Used in Diabetes Research:
1-(2-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)ethyl)-4-(2-methoxyphenyl)piperazine is used as a research compound for exploring its potential in diabetes treatment, as GSK-3 inhibition may play a role in regulating glucose metabolism and insulin signaling.
Used in Neurodegenerative Disorder Research:
1-(2-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)ethyl)-4-(2-methoxyphe nyl)piperazine is also used in the study of neurodegenerative disorders, given its potential to inhibit GSK-3, which has been implicated in the pathogenesis of conditions such as Alzheimer's and Parkinson's disease.
Used in Drug Development:
1-(2-((3,4-Dihydro-2H-1-benzothiopyran-8-yl)oxy)ethyl)-4-(2-methoxyphenyl)piperazine serves as a lead compound in the development of new drugs targeting GSK-3 for the treatment of various medical conditions, including those mentioned above.
Check Digit Verification of cas no
The CAS Registry Mumber 153804-42-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,8,0 and 4 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 153804-42:
(8*1)+(7*5)+(6*3)+(5*8)+(4*0)+(3*4)+(2*4)+(1*2)=123
123 % 10 = 3
So 153804-42-3 is a valid CAS Registry Number.
InChI:InChI=1/C22H28N2O2S/c1-25-20-9-3-2-8-19(20)24-13-11-23(12-14-24)15-16-26-21-10-4-6-18-7-5-17-27-22(18)21/h2-4,6,8-10H,5,7,11-17H2,1H3
153804-42-3Relevant academic research and scientific papers
THIOCHROMAN COMPOUNDS
-
, (2008/06/13)
The invention relates to compounds of the formula I: STR1 in which R 1 is as defined in the description, their optical isomers and their addition salts with a pharmaceutically-acceptable acid or base, andmedicinal products which are useful for treating Central Nervous System disorders.
